Current Edition

Current features

FDA Focus on the Safety of Gene Therapy Products

Within the past 6 years, the US Food and Drug Administration (FDA) has approved a growing number of cellular and gene therapy products to treat a variety of conditio...
Continue Reading →
Volume 15 Issue 2

Exploring the Limb Girdle Muscular Dystrophy Clinical Trial Landscape

With the recent advent of adeno-associated, virus-based gene therapy treatments, limb-girdle muscular dystrophy (LGMD) is currently attracting the attention of the b...
Continue Reading →